Skip to content
TrialScanner

NCT07011706

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

Phase 2Active, not recruitingACRSLead

Registry record

Lead sponsor
Aclaris Therapeutics, Inc.
Conditions
Atopic Dermatitis; Atopic; Dermatitis; AD; Eczema
Primary completion
Sep 21, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT07011706 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.